Finance and Audit Committee

Charter 

In order to provide independent financial oversight to ISCT to enable long term financial health for the Society, the Finance and Audit Committee aims:

  • To provide financial oversight in line with strategic objectives for the Society
  • To provide financial stewardship of ISCT in both the short and long term horizon
  • To monitor Society management costs in relation to ISCT growth and expectations
  • To advise on insurance and risk liability assessments; and major decisions that affect the Society's financial health 
  • To ensure short term operational decisions do not bias the Society's longer term financial strategy and sustainability
  • To support auditor selection and provide audit oversight
  • To provide legal and regulatory oversight ensuring
    • ongoing operational procedures and contracts are in compliance with the non-profit status of the Society
    • compliance with all tax authorities where the Society conducts its Annual and Regional Meetings
    • compliance with US banking requirements
    • Large contract(s) risk review
  • To provide risk review of trademarks, copyrights, and Domain names

Committee Members

 

 

Emily Culme-Seymour, PhD
Chair
ISCT Global Treasurer 2014-2017
GSK Rare Diseases Unit
London, United Kingdom

 

Catherine Bollard, MBChB, MD
Children's National Health System and The George Washington University
Washington, DC, United States
Christopher Bravery, PhD
Consulting on Advanced Biologicals Ltd.
London, United Kingdom 
Edwin Horwitz, MD, PhD
Nationwide Children's Hospital
Columbus, OH, United States
Queenie Jang, BSc(Pharmacy), MBA
ISCT Executive Director
Vancouver, BC, Canada
John Rasko, AO, MBBS, PhD, FRCPA, FRACP, FAHMS
Royal Prince Alfred Hospital
Sydney, Australia
 
   

 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.